<?xml version='1.0' encoding='utf-8'?>
<document id="22493814"><sentence text="[Enantioselective determinination of R-warfarin/S-warfarin in human plasma using liquid chromatography-tandem mass spectrometry and its application in a drug-drug interaction study]."><entity charOffset="37-47" id="DDI-PubMed.22493814.s1.e0" text="R-warfarin" /><entity charOffset="48-58" id="DDI-PubMed.22493814.s1.e1" text="S-warfarin" /><pair ddi="false" e1="DDI-PubMed.22493814.s1.e0" e2="DDI-PubMed.22493814.s1.e0" /><pair ddi="false" e1="DDI-PubMed.22493814.s1.e0" e2="DDI-PubMed.22493814.s1.e1" /></sentence><sentence text="To study the drug-drug interaction of morinidazole and warfarin and its application, a sensitive and rapid liquid chromatography-tandem mass spectrometric (LC-MS/MS) method was developed for the determination of R-warfarin/S-warfarin in human plasma"><entity charOffset="38-50" id="DDI-PubMed.22493814.s2.e0" text="morinidazole" /><entity charOffset="212-222" id="DDI-PubMed.22493814.s2.e1" text="R-warfarin" /><entity charOffset="223-233" id="DDI-PubMed.22493814.s2.e2" text="S-warfarin" /><pair ddi="false" e1="DDI-PubMed.22493814.s2.e0" e2="DDI-PubMed.22493814.s2.e0" /><pair ddi="false" e1="DDI-PubMed.22493814.s2.e0" e2="DDI-PubMed.22493814.s2.e1" /><pair ddi="false" e1="DDI-PubMed.22493814.s2.e0" e2="DDI-PubMed.22493814.s2.e2" /><pair ddi="false" e1="DDI-PubMed.22493814.s2.e1" e2="DDI-PubMed.22493814.s2.e1" /><pair ddi="false" e1="DDI-PubMed.22493814.s2.e1" e2="DDI-PubMed.22493814.s2.e2" /></sentence><sentence text=" In a random, two-period crossover study, 12 healthy volunteers received a single oral dose of 5 mg racemic warfarin in the absence and presence of morinidazole"><entity charOffset="148-160" id="DDI-PubMed.22493814.s3.e0" text="morinidazole" /></sentence><sentence text=" Blood samples were collected according to a pre-designed time schedule" /><sentence text=" R-warfarin, S-warfarin and methyclothiazide were extracted with ethylether : methylenechloride (3 : 2), then separated on a Astec Chirobiotic V (150 mm x 4"><entity charOffset="1-11" id="DDI-PubMed.22493814.s5.e0" text="R-warfarin" /><entity charOffset="13-23" id="DDI-PubMed.22493814.s5.e1" text="S-warfarin" /><entity charOffset="28-44" id="DDI-PubMed.22493814.s5.e2" text="methyclothiazide" /><entity charOffset="65-75" id="DDI-PubMed.22493814.s5.e3" text="ethylether" /><entity charOffset="78-95" id="DDI-PubMed.22493814.s5.e4" text="methylenechloride" /><pair ddi="false" e1="DDI-PubMed.22493814.s5.e0" e2="DDI-PubMed.22493814.s5.e0" /><pair ddi="false" e1="DDI-PubMed.22493814.s5.e0" e2="DDI-PubMed.22493814.s5.e1" /><pair ddi="false" e1="DDI-PubMed.22493814.s5.e0" e2="DDI-PubMed.22493814.s5.e2" /><pair ddi="false" e1="DDI-PubMed.22493814.s5.e0" e2="DDI-PubMed.22493814.s5.e3" /><pair ddi="false" e1="DDI-PubMed.22493814.s5.e0" e2="DDI-PubMed.22493814.s5.e4" /><pair ddi="false" e1="DDI-PubMed.22493814.s5.e1" e2="DDI-PubMed.22493814.s5.e1" /><pair ddi="false" e1="DDI-PubMed.22493814.s5.e1" e2="DDI-PubMed.22493814.s5.e2" /><pair ddi="false" e1="DDI-PubMed.22493814.s5.e1" e2="DDI-PubMed.22493814.s5.e3" /><pair ddi="false" e1="DDI-PubMed.22493814.s5.e1" e2="DDI-PubMed.22493814.s5.e4" /><pair ddi="false" e1="DDI-PubMed.22493814.s5.e2" e2="DDI-PubMed.22493814.s5.e2" /><pair ddi="false" e1="DDI-PubMed.22493814.s5.e2" e2="DDI-PubMed.22493814.s5.e3" /><pair ddi="false" e1="DDI-PubMed.22493814.s5.e2" e2="DDI-PubMed.22493814.s5.e4" /><pair ddi="false" e1="DDI-PubMed.22493814.s5.e3" e2="DDI-PubMed.22493814.s5.e3" /><pair ddi="false" e1="DDI-PubMed.22493814.s5.e3" e2="DDI-PubMed.22493814.s5.e4" /></sentence><sentence text="6 mm ID, 5 microm) column using 5 mmol x L(-1) ammonium acetate (pH 4" /><sentence text="0) - acetonitrile as mobile phase at a flow-rate of 1"><entity charOffset="0-17" id="DDI-PubMed.22493814.s7.e0" text="0) - acetonitrile" /></sentence><sentence text="5 mL x min(-1)" /><sentence text=" The mobile phase was splitted and 0" /><sentence text="5 mL x min(-1) was introduced into MS" /><sentence text=" A tandem mass spectrometer equipped with electrospray ionization source was used as detector and operated in the negative ion mode" /><sentence text=" Quantification was performed using multiple reaction monitoring (MRM)" /><sentence text=" The resolution of warfarin enantiomers is 1"><entity charOffset="19-27" id="DDI-PubMed.22493814.s13.e0" text="warfarin" /></sentence><sentence text="56" /><sentence text=" The linear calibration curves for R-warfarin and S-warfarin both were obtained in the concentration range of 5 - 1 000 ng x mL(-1)"><entity charOffset="35-45" id="DDI-PubMed.22493814.s15.e0" text="R-warfarin" /><entity charOffset="50-60" id="DDI-PubMed.22493814.s15.e1" text="S-warfarin" /><pair ddi="false" e1="DDI-PubMed.22493814.s15.e0" e2="DDI-PubMed.22493814.s15.e0" /><pair ddi="false" e1="DDI-PubMed.22493814.s15.e0" e2="DDI-PubMed.22493814.s15.e1" /></sentence><sentence text=" Intra- and inter-day relative standard deviation (RSD) for R-warfarin and S-warfarin over the entire concentration range across three validation runs was both less than 10%, and relative error (RE) ranged from -4"><entity charOffset="60-70" id="DDI-PubMed.22493814.s16.e0" text="R-warfarin" /><entity charOffset="75-85" id="DDI-PubMed.22493814.s16.e1" text="S-warfarin" /><pair ddi="false" e1="DDI-PubMed.22493814.s16.e0" e2="DDI-PubMed.22493814.s16.e0" /><pair ddi="false" e1="DDI-PubMed.22493814.s16.e0" e2="DDI-PubMed.22493814.s16.e1" /></sentence><sentence text="9% to 0" /><sentence text="7%, separately" /><sentence text=" The method herein described is effective and convenient, and suitable for the study of metabolic interaction between morinidazole and warfarin"><entity charOffset="118-130" id="DDI-PubMed.22493814.s19.e0" text="morinidazole" /></sentence><sentence text=" The results showed that coadministration of warfarin with morinidazole did not affect the pharmacokinetics of either R-warfarin or S-warfarin"><entity charOffset="45-53" id="DDI-PubMed.22493814.s20.e0" text="warfarin" /><entity charOffset="59-71" id="DDI-PubMed.22493814.s20.e1" text="morinidazole" /><entity charOffset="118-128" id="DDI-PubMed.22493814.s20.e2" text="R-warfarin" /><entity charOffset="132-142" id="DDI-PubMed.22493814.s20.e3" text="S-warfarin" /><pair ddi="false" e1="DDI-PubMed.22493814.s20.e0" e2="DDI-PubMed.22493814.s20.e0" /><pair ddi="false" e1="DDI-PubMed.22493814.s20.e0" e2="DDI-PubMed.22493814.s20.e1" /><pair ddi="false" e1="DDI-PubMed.22493814.s20.e0" e2="DDI-PubMed.22493814.s20.e2" /><pair ddi="false" e1="DDI-PubMed.22493814.s20.e0" e2="DDI-PubMed.22493814.s20.e3" /><pair ddi="false" e1="DDI-PubMed.22493814.s20.e1" e2="DDI-PubMed.22493814.s20.e1" /><pair ddi="false" e1="DDI-PubMed.22493814.s20.e1" e2="DDI-PubMed.22493814.s20.e2" /><pair ddi="false" e1="DDI-PubMed.22493814.s20.e1" e2="DDI-PubMed.22493814.s20.e3" /><pair ddi="false" e1="DDI-PubMed.22493814.s20.e2" e2="DDI-PubMed.22493814.s20.e2" /><pair ddi="false" e1="DDI-PubMed.22493814.s20.e2" e2="DDI-PubMed.22493814.s20.e3" /></sentence><sentence text="" /></document>